Published Date: 02 Mar 2023
High-risk melanoma patients who received the drug pembrolizumab before or after surgery to remove the cancer had a higher risk of developing melanoma than those who did not have a similar condition that eliminated cancer cells.
Read Full News1.
Patients with head and neck cancer who cannot receive cisplatin now have new hope.
2.
The Boom in ADHD Coaching Has Few Rules
3.
Q&A: Why adolescents and young adults with cancer are falling behind
4.
Adaptive SABR-Used Hypofractionated Chemoradiation Showed Good Results in NSCLC.
5.
Making informed decisions and managing regret after prostate cancer treatment
1.
Clonal Evolution Genomics in Dynamic Tumor Ecosystems
2.
Understanding Mesenteric Masses: Symptoms, Diagnosis, and Treatment Options
3.
Critical Care Updates on Hematopoietic Dysfunction During Prolonged Critical Illness
4.
Exploring the Causes and Treatment of Granulocytopenia: A Comprehensive Guide
5.
Artificial Intelligence in Oncology: Current Trends, Challenges and Future Outlook
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation